Miss call 9015611166
Best Stock Tip

A1 Intraday tips Android App for Share Traders

Get APP link by sms

Join our Telegram Channel to Get Free Stock Tips for Life Time


Celestial Biolabs Ltd share price today (on 1 October 2023).

We Provide Best stock tips for Celestial Biolabs Ltd. A1 Intraday Tips is accurate share tips Provider Company in India in Nse market. A1 Intraday Tips, also provide Daily Charts with Nse Share Market current price of Celestial Biolabs Ltd with today performance in nse market. Contact Us for Jackpot Stock tips.

Get Free Stock Tips for Celestial Biolabs Ltd

BSE: 532871 | NSE: CELESTIAL | ISIN: INE221I01017 Market Cap: [Rs.Cr.] 24 | Face Value: [Rs.] 10 Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Celestial Biolabs Ltd (CBL) is an ISO 9001-2000 certified company with a decade of experience in Insilico Drug Discovery and Development, and contract research services.Celestial Biolabs is recognized by DSIR (Government of India) for its R&D endeavors in the Insilco Drug Discovery software development.Celestial has been providing customized solutions and services in Bio-IT as well as research services over a decade.
CELESTIAL LABS LIMITED was incorporated as a Private Limited Company on November 19, 1997 as 'Celestial Technologies Private Limited'. Mr. Rajani Kanth Katragadda and Mr. Vijay Marur have promoted the company. The company was later converted into a Public Limited Company under the name 'Celestial Technologies Limited' on December 6, 1999 and has been subsequently renamed as 'CELESTIAL LABS LIMITED' effective from February 13, 2004. The present promoter of the company is Mr. Aditya Narayan Singh. The Original promoters sold their holding to the present promoter on 7.11.1998. The company has received ISO 9001-2000 certificate. The company has been providing customized enterprise solutions, bioinformatics services and also involved in development of biopharmaceuticals and industrial enzymes.
The company is in contact with Centre for Cellular & Molecular Biology (CCMB) under the aegis of Council for Scientific and Industrial Research, Ministry of Science and Technology, Government of India and Indian Institute of Chemical Technology (IICT), premier chemical and Biological Institutions in Hyderabad to work on collaborative research projects to be funded by Department of Science and Technology New Delhi. The Company has offer both service and solutions like application management for legacy system, upgrade and maintenance system. Molecular informatics, data management, algorithm development, compliances and data curation, warehousing and visualization and custom built application are the current part of services. To strengthen the Drug molecule development and related services like Target identification and advance fragment based lead optimization solution, Celestial has developed a de novo drug design tool 'CELSUITE' to aid the pharma industry in finding the lead molecules for drug discovery and protected the IPR by filing under the Copyright Act, 1957.
(Appraised and funded by Department of Science and Technology, New Delhi). The company is setting up an Industrial biotechnology facility to manufacture industrial enzymes. This facility would also include the Development laboratories for carrying out further R & D activities to develop new related products for reducing Wrinkles / Stretch marks and acceleration of wound healing from the same chemical structure of vitiligo. The proposed Facility is being set up at Shapoorji Pallonji Biotech Park in Genome Valley at Hyderabad in Andhra Pradesh.
According to the Individual - Audited financial statement for the Year of 2012, total net operating revenues decreased with -19.12%, from INR 25.32 tens of millions to INR 20.48 tens of millions. Operating result decreased from INR 6.06 tens of millions to INR 4.26 tens of millions which means -29.70% change. The results of the period decreased -61.98% reaching INR 0.92 tens of millions at the end of the period against INR 2.42 tens of millions last year. Return on equity (Net income/Total equity) went from 0.82% to 0.31%, the Return On Asset (Net income / Total Asset) went from 3.16% to 1.27% and the Net Profit Margin (Net Income/Net Sales) went from 9.56% to 4.49% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 4.49% compared to 4.17% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 8.07 to 24.80 when compared to the previous year.

Our all intraday stock tips
( Equity cash, Nse fno, jackpot call, sure shot call, btst/stbt call )
Under one plan with lowest price
for free trial visit Stock tips for day Traders

Nse Listed Companies with Live Charts

(Click on an alphabet below to get a list of nse listed companies
with live charts starting with that Alphabet.)